Stoke Therapeutics Statistics
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
26.81-0.12 (-0.45%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Stoke Therapeutics by the numbers
Stoke Therapeutics has a market capitalization of $1.75 billion based on 65.41M shares outstanding. With trailing EPS of $-3.81, Stoke Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.5% above its 50-day average and 12.6% below its 200-day average.
Average daily trading volume is 1.02M shares, or about $27.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
STOK valuation vs. peer median
| Metric | STOK | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.75B | $1.78B | -2% |
| Avg. volume | 1.02M | 958.02K | +6% |
Peer median across 8 companies: ETON, TRAX, SDGR, ZYME, KRSA, MRVI, SEPN, VERA.
Valuation
- Market cap
- $1.75B
- Price / sales (latest FY)
- 9.51
- EPS (TTM)
- $-3.81
- Shares outstanding
- 65.41M
Price and trading
- Previous close
- 26.93
- Open
- 26.35
- Day range
- 25.94 – 27.78
- 52-week range
- 22.05 – 40.22
- 52-week change
- -8.62%
- Beta
- —
- Volume
- 615.75K
- Average volume
- 1.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 1.75B
- Forward Pe
- -6.56
- Eps
- -3.81
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.22
- Week52 Low
- 22.05
- Avg Volume
- 1.02M
- Shares Outstanding
- 65.41M
- Ma50
- 26.16
- Ma200
- 30.67
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -33.34%
- Pct From52w Low
- 21.59%